5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine

被引:88
作者
Frantz, KJ [1 ]
Hansson, KJ [1 ]
Stouffer, DG [1 ]
Parsons, LH [1 ]
机构
[1] Scripps Res Inst, Res Inst, Dept Neuropharmacol CVN7, La Jolla, CA 92037 USA
关键词
5-HT6; receptors; SB; 258510A; serotonin; dopamine; nucleus accumbens; frontal cortex; amphetamine; cocaine; microdialysis self-administration;
D O I
10.1016/S0028-3908(01)00165-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The localization of serotonin 5-HT6 receptors in limbic and motor brain regions, and the high affinity of these receptors for several antipsychotic agents, suggest that they may be involved in motor activity, reward-related behaviors, and psychotic disorders. The present study characterized the effects of a novel 5-HT6 receptor antagonist, SB 258510A, on psychostimulant-induced motor activity, self-administration, and increases in extracellular dopamine in the nucleus accumbens and frontal cortex of male Wistar rats. The locomotor-activating effects of amphetamine (1 mg/kg) were dose-dependently enhanced by pretreatment with SB 258510A (3, 10 mg/kg). Similarly, amphetamine self-administration was dose-dependently altered by SB 258510A in a manner indicative of enhanced reinforcing effects of amphetamine on both fixed and progressive ratio schedules or reinforcement. SB 258510A treatment had no effect on either cocaine-induced locomotor activity or cocaine self-administration. Dual-probe in vivo microdialysis revealed that pretreatment with 3 mg/kg SB 258510A potentiated an amphetamine-induced increase in extracellular dopamine more robustly in the frontal cortex than in the nucleus accumbens. These data indicate that activation of 5-HT6 receptors may regulate behaviors related to amphetamine but not cocaine, and point to the frontal cortex as a possible site of action for these effects. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:170 / 180
页数:11
相关论文
共 56 条
[1]   Neuropharmacological mechanisms of drug reward: Beyond dopamine in the nucleus accumbens [J].
Bardo, MT .
CRITICAL REVIEWS IN NEUROBIOLOGY, 1998, 12 (1-2) :37-67
[2]   Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].
Bentley, JC ;
Bourson, A ;
Boess, FG ;
Fone, KCF ;
Marsden, CA ;
Petit, N ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542
[3]   Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells [J].
Boess, FG ;
Monsma, FJ ;
Carolo, C ;
Meyer, V ;
Rudler, A ;
Zwingelstein, C ;
Sleight, AJ .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :713-720
[4]  
BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
[5]   5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist [J].
Bromidge, SM ;
Brown, AM ;
Clarke, SE ;
Dodgson, K ;
Gager, T ;
Grassam, HL ;
Jeffrey, PM ;
Joiner, GF ;
King, FD ;
Middlemiss, DN ;
Moss, SF ;
Newman, H ;
Riley, G ;
Routledge, C ;
Wyman, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :202-205
[6]  
Caine SB, 1993, BEHAV NEUROSCIENCE P, P117
[7]  
Darracq L, 1998, J NEUROSCI, V18, P2729
[8]   In vivo effects of the 5-HT6 antagonist SE-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate [J].
Dawson, LA ;
Nguyen, HQ ;
Li, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :23-26
[9]  
Drew AE, 2000, SYNAPSE, V38, P10, DOI 10.1002/1098-2396(200010)38:1<10::AID-SYN2>3.3.CO
[10]  
2-K